Arend B. Mulder

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 85 publications

Beneficial effect of PTCy and a short duration of immune suppression on relapse risk in acute myeloid leukemia patients with pretransplant MRD.

Beneficial effect of PTCy and a short duration of immune suppression on relapse risk in acute myeloid leukemia patients with pretransplant MRD.

Journal: Bone marrow transplantation

Published: November 28, 2024

Chimeric HLA antibody receptor T cells for targeted therapy of antibody-mediated rejection in transplantation.

Chimeric HLA antibody receptor T cells for targeted therapy of antibody-mediated rejection in transplantation.

Journal: HLA

Published: April 11, 2023

Experiences from 4 Years of Organization of an External Quality Assessment for Mycobacterium tuberculosis Whole-Genome Sequencing in the European Union/European Economic Area.

Experiences from 4 Years of Organization of an External Quality Assessment for Mycobacterium tuberculosis Whole-Genome Sequencing in the European Union/European Economic Area.

Journal: Microbiology spectrum

Published: December 08, 2022

Phagocytosis of platelets opsonized with differently glycosylated anti-HLA hIgG1 by monocyte-derived macrophages.

Phagocytosis of platelets opsonized with differently glycosylated anti-HLA hIgG1 by monocyte-derived macrophages.

Journal: Platelets

Published: October 03, 2022

Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease cathepsin S.

Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease cathepsin S.

Journal: Journal for immunotherapy of cancer

Published: February 02, 2022

Fc galactosylation of anti-platelet human IgG1 alloantibodies enhances complement activation on platelets.

Fc galactosylation of anti-platelet human IgG1 alloantibodies enhances complement activation on platelets.

Journal: Haematologica

Published: December 13, 2021

A Comprehensive Evaluation of the Antibody-Verified Status of Eplets Listed in the HLA Epitope Registry.

A Comprehensive Evaluation of the Antibody-Verified Status of Eplets Listed in the HLA Epitope Registry.

Journal: Frontiers in immunology

Published: October 24, 2021

An HLA-A*11:01-Binding Neoantigen from Mutated NPM1 as Target for TCR Gene Therapy in AML.

An HLA-A*11:01-Binding Neoantigen from Mutated NPM1 as Target for TCR Gene Therapy in AML.

Journal: Cancers

Published: September 29, 2021

Precision Engineering of an Anti-HLA-A2 Chimeric Antigen Receptor in Regulatory T Cells for Transplant Immune Tolerance.

Precision Engineering of an Anti-HLA-A2 Chimeric Antigen Receptor in Regulatory T Cells for Transplant Immune Tolerance.

Journal: Frontiers in immunology

Published: March 26, 2021

The SPPL3-defined glycosphingolipid repertoire orchestrates HLA class I-mediated immune responses.

The SPPL3-defined glycosphingolipid repertoire orchestrates HLA class I-mediated immune responses.

Journal: Immunity

Published: February 10, 2021

Two Human Monoclonal HLA-Reactive Antibodies Cross-React with Mamu-B*008, a Rhesus Macaque MHC Allotype Associated with Control of Simian Immunodeficiency Virus Replication.

Two Human Monoclonal HLA-Reactive Antibodies Cross-React with Mamu-B*008, a Rhesus Macaque MHC Allotype Associated with Control of Simian Immunodeficiency Virus Replication.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: December 14, 2020

ERAP2 Increases the Abundance of a Peptide Submotif Highly Selective for the Birdshot Uveitis-Associated HLA-A29.

ERAP2 Increases the Abundance of a Peptide Submotif Highly Selective for the Birdshot Uveitis-Associated HLA-A29.

Journal: Frontiers in immunology

Published: November 27, 2020

Showing 1-12 of 85

Last Updated: 09/26/2026